Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Hoon Lee

Showing results (31-40 of 513) with videos related to

Pageof 52
Sort By:
Immune Network|March 9, 2026
Harnessing the Gut Microbiota to Improve Cancer Immunotherapy: Focus on Lung CancerUni Park, Jun-Yeong Heo, Seung-Min Chun, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2020
Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study)Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, et al.
Thoracic Cancer|December 31, 2021
The rarest of rare cases within the one thousand faces of atypical carcinoid: Pseudomesotheliomatous manifestation in a pregnant womanHarim Kim, Ho Yun Lee, Se-Hoon Lee, et al.
Expert Opinion on Biological Therapy|January 23, 2016
Pembrolizumab for the treatment of non-small cell lung cancerSung Hee Lim, Jong-Mu Sun, Se-Hoon Lee, et al.
The Korean Journal of Internal Medicine|April 22, 2016
WITHDRAWN:Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failureKyoung Min Cho, Bhumsuk Keam, Tae Min Kim, et al.
Translational Oncology|January 17, 2013
Analysis of the BRAF(V600E) Mutation in Central Nervous System TumorsJae Kyung Myung, Hwajin Cho, Chul-Kee Park, et al.
Cancer Research and Treatment|January 3, 2023
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung CancerHyun Ae Jung, Sehhoon Park, Se-Hoon Lee, et al.
Plos One|October 6, 2022
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinomaJoon Young Hur, Bo Mi Ku, Sehhoon Park, et al.
Expert Review of Molecular Diagnostics|August 26, 2017
An update on biomarkers for kinase inhibitor response in non-small-cell lung cancerBo Mi Ku, Jong-Mu Sun, Se-Hoon Lee, et al.
Frontiers in Oncology|January 28, 2026
Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancerSandip Pravin Patel, Justin Gainor, Steven Kao, et al.
Pageof 52

Showing results (31-40 of 513) with videos related to

Sort By:
Pageof 52
Immune Network|March 9, 2026
Harnessing the Gut Microbiota to Improve Cancer Immunotherapy: Focus on Lung CancerUni Park, Jun-Yeong Heo, Seung-Min Chun, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2020
Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study)Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, et al.
Thoracic Cancer|December 31, 2021
The rarest of rare cases within the one thousand faces of atypical carcinoid: Pseudomesotheliomatous manifestation in a pregnant womanHarim Kim, Ho Yun Lee, Se-Hoon Lee, et al.
Expert Opinion on Biological Therapy|January 23, 2016
Pembrolizumab for the treatment of non-small cell lung cancerSung Hee Lim, Jong-Mu Sun, Se-Hoon Lee, et al.
The Korean Journal of Internal Medicine|April 22, 2016
WITHDRAWN:Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failureKyoung Min Cho, Bhumsuk Keam, Tae Min Kim, et al.
Translational Oncology|January 17, 2013
Analysis of the BRAF(V600E) Mutation in Central Nervous System TumorsJae Kyung Myung, Hwajin Cho, Chul-Kee Park, et al.
Cancer Research and Treatment|January 3, 2023
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung CancerHyun Ae Jung, Sehhoon Park, Se-Hoon Lee, et al.
Plos One|October 6, 2022
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinomaJoon Young Hur, Bo Mi Ku, Sehhoon Park, et al.
Expert Review of Molecular Diagnostics|August 26, 2017
An update on biomarkers for kinase inhibitor response in non-small-cell lung cancerBo Mi Ku, Jong-Mu Sun, Se-Hoon Lee, et al.
Frontiers in Oncology|January 28, 2026
Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancerSandip Pravin Patel, Justin Gainor, Steven Kao, et al.
Pageof 52